Replies to post #398798 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

If L had been a failure, it would be a difficult roe to hoe forward for Direct. By waiting, they are able to demonstrate L's effectiveness, which also paves the way forward for DCVax as a standard of care for many solid cancers. Of course, they must prove efficacy for the various indications, but Ike's point was that without the wait, they wouldn't have been able to get out of the gate.

[biosectinvestor]

This is not true. Here is one such biomarker approval…

https://www.businesswire.com/news/home/20200617005198/en/FDA-Approves-Second-Biomarker-Based-Indication-for-Merck’s-KEYTRUDA®-pembrolizumab-Regardless-of-Tumor-Type